Principal Ai&Ml Scientist – Evinova

On average, it takes more than 10 years to develop a drug and costs more than $1.3 billion. Over 70 % of drug R&D costs are spent on clinical development, yet the success rate from phase I to approval is only around 10%. At Evinova, a new health tech business as part of the Astra Zeneca Group, is on a mission to increase clinical trial success rates by 20%, accelerate clinical development timelines by 36 months, and reduce study costs by 50% by leveraging state‑of‑the‑art AI and machine learning. If you are a rigorous modeler with hands‑on experience designing and validating ML solutions, a strong grounding in statistics and modern machine learning, a talent for turning data into trustworthy decisions, and a voracious learner, you could be a fantastic fit for our team. Talent with ambition to grow into leadership roles will be a key differentiator for successful candidates. Glass‑ceiling smashers especially welcome. Responsibilities Partner directly with Clinical Operations and Clinica...